CYTOKINETICS INC — Director's Dealing 2024

Sep 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-09-17

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-17	Common Stock	M	5300	$7.96	Acquired	128220	Direct
2024-09-17	Common Stock	S	5300	$56.77	Disposed	122920	Direct
2024-09-17	Common Stock	S	2000	$56.76	Disposed	120920	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-17	Non-Qualified Stock Option (Right to Buy)	$7.96	M	5300	Disposed	2025-02-26	Common Stock (5300)	Direct